ZA931700B - Use of L-carnitine for treating carnitine-depleted HIV-seropositive patients - Google Patents

Use of L-carnitine for treating carnitine-depleted HIV-seropositive patients

Info

Publication number
ZA931700B
ZA931700B ZA931700A ZA931700A ZA931700B ZA 931700 B ZA931700 B ZA 931700B ZA 931700 A ZA931700 A ZA 931700A ZA 931700 A ZA931700 A ZA 931700A ZA 931700 B ZA931700 B ZA 931700B
Authority
ZA
South Africa
Prior art keywords
carnitine
treating
seropositive patients
depleted hiv
depleted
Prior art date
Application number
ZA931700A
Inventor
Claudio De Simone
Original Assignee
Sigma Tau Ind Famaceutiche Riu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Famaceutiche Riu filed Critical Sigma Tau Ind Famaceutiche Riu
Publication of ZA931700B publication Critical patent/ZA931700B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA931700A 1992-03-11 1993-03-10 Use of L-carnitine for treating carnitine-depleted HIV-seropositive patients ZA931700B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM920165A IT1255039B (en) 1992-03-11 1992-03-11 USE OF L-CARNITINE IN THE TREATMENT OF HIV-SEROPOSITIVE PATIENTS PRESENTING CARNITINE DEFICIT.

Publications (1)

Publication Number Publication Date
ZA931700B true ZA931700B (en) 1993-11-16

Family

ID=11400792

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA931700A ZA931700B (en) 1992-03-11 1993-03-10 Use of L-carnitine for treating carnitine-depleted HIV-seropositive patients

Country Status (5)

Country Link
EP (1) EP0560275A1 (en)
JP (1) JPH069387A (en)
KR (1) KR0148350B1 (en)
IT (1) IT1255039B (en)
ZA (1) ZA931700B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1277897B1 (en) * 1995-08-03 1997-11-12 Mendes Srl USE OF L-CARNITINE, ITS DERIVATIVES AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS IN COMBINATION WITH ANTIRETROVIRAL DRUGS TO REDUCE
LV13544B (en) 2005-08-15 2007-05-20 Grindeks As Pharmaceutical composition containing reverse transcriptase inhibitor and meldonium

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2921852A1 (en) * 1979-05-29 1980-12-11 Fresenius Chem Pharm Ind LIPID LOWERING AGENT
IT1143214B (en) * 1981-07-09 1986-10-22 Sigma Tau Ind Farmaceuti ACIL DERIVED FROM CARNITINE AS IMMUNOMODULATOR

Also Published As

Publication number Publication date
ITRM920165A1 (en) 1993-09-11
ITRM920165A0 (en) 1992-03-11
KR0148350B1 (en) 1998-11-02
KR930019207A (en) 1993-10-18
IT1255039B (en) 1995-10-13
EP0560275A1 (en) 1993-09-15
JPH069387A (en) 1994-01-18

Similar Documents

Publication Publication Date Title
HU9203626D0 (en) Dipyridamole preparatives for treatment of proliferative deseases
HU9300536D0 (en) Compounds of medical effect
GB9208921D0 (en) Electrochemical treatment of surfaces
EP0584340A4 (en) Diagnosis and treatment of various neuralgias
IL101410A0 (en) Formulation for the treatment of cancer
EP0577023A3 (en) Angiotensin-ii receptor-antagonists for the treatment of arrhythmices
HU9302183D0 (en) Medical preparatives for preventing and treating osteoporises after menopausa
GB9222260D0 (en) Skin treatment
ZA932303B (en) Medicament for the treatment of airways inflammation and airways hyperresponsiveness
GB9217124D0 (en) Medical treatment
ZA931700B (en) Use of L-carnitine for treating carnitine-depleted HIV-seropositive patients
GB9202196D0 (en) Method of treatment
GB9216360D0 (en) Treatment of blood
GB9201193D0 (en) Treatment of liquids
GB2266241B (en) Treatment of pastures
GB9201391D0 (en) Method of treatment
GB9218773D0 (en) Skin treatment
GB9207595D0 (en) Treatment of pastures
GB9212535D0 (en) Treatment of boimass
BG95257A (en) Preparation and method for the treatment of paradontosis
BG98001U (en) Medicament for the treatment of hyperkeratotic conditions of the skin
GB9222195D0 (en) Medical treatment
GB9204062D0 (en) Medical treatment
BG96534A (en) Method and device for therapy of patients
GB9125670D0 (en) Treatment of neurogical conditions